May 22, 2026
Small Molecules Market (By Product Lifecycle: Patented/Innovator Small-Molecule Brands, Generics, OTC/Non-prescription; By Therapeutic Area: Oncology, Cardiometabolic, CNS/Psychiatry & Neurology, Infectious Diseases, Respiratory & Allergy, Ga...
April 21, 2026
Projections indicate that, small nucleic acid drug industry is projected to rise from USD 5.94 billion in 2024 to USD 33.28 billion by 2034, reflecting a CAGR of 18.84% over the next decade. The rising prevalence of chronic disorders and the growing ...
April 21, 2026
According to market projections, the small molecule API sector is expected to grow from USD 206.9 billion in 2025 to USD 374.03 billion by 2035, reflecting a CAGR of 6.1%. The small molecule API market is growing due to rising investment by key playe...
April 21, 2026
The GLP-1 small molecule market covers comprehensive insights on global market size, segmentation, regional performance, and competitive dynamics across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The market ...
April 21, 2026
Forecasts suggest that the small molecule CDMO market will expand from USD 72.81 billion in 2024 to USD 145.12 billion by 2034, with a CAGR of 7.14% during this period. In 2024, North America led the small molecule CDMO market, with APIs holding the ...
January 07, 2026
Market insights predict the global small scale bioreactors industry will increase from USD 2.63 billion in 2025 to USD 10.49 billion by 2035, achieving a CAGR of 14.84%. The growing demand for biopharmaceuticals and technological advancements drives ...
February 11, 2026
According to our projections, the global small molecule CMC service market was valued at USD 801.3 million in 2025 and reached USD 831.35 million in 2026, and it is projected to expand to approximately USD 1,157.91 million by 2035, growing at a CAGR ...
April 21, 2026
According to market projections, small molecule inhibitor market was valued at USD 310.38 billion in 2025 and is expected to reach USD 328.22 billion by 2026, further expanding to around USD 542.87 billion by 2035, growing at a CAGR of 5.75% from 202...
April 07, 2026
Small Molecule Drug Discovery Outsourcing Market (By Drug Discovery Phase: Target Identification & Validation, Hit Identification, Hit-to-Lead (H2L), Lead Optimization, Preclinical Development; By Service Type: Medicinal Chemistry Services, Biolo...
April 21, 2026
Market insights predict, the non-small cell lung cancer therapeutics industry is expected to grow from USD 21.5 billion in 2024 to USD 71.2 billion by 2034, driven by a CAGR of 12.74%. The non-small cell lung cancer therapeutics market is expanding d...
April 21, 2026
Market insights predict the global non-small lung carcinoma industry will increase from USD 9.1 billion in 2024 to USD 23.67 billion by 2034, achieving a CAGR of 10.03%. Clinical research, development of new treatment options, and prevalence of NSCLC...
May 04, 2026
Small Interfering RNA (siRNA) Market (By Type: Synthetic siRNA, Dicer-substrate siRNA (DsiRNA), Short Hairpin RNA (shRNA0); By Delivery Method: Lipid-based Delivery, Polymer-based Delivery, Conjugate-based Delivery, Viral delivery systems, Other Deli...
May 21, 2026
Small Molecule Innovator API CDMO Market (By Stage Type: Preclinical, Clinical, Phase I, Phase II, Phase III, Commercial; By Customer Type: Pharmaceutical, Small, Medium, Large, Biotechnology, Small, Medium, Large; By Therapeutic Area: Cardiovascular...
May 21, 2026
Small Molecule CMO and CDMO Market (By Product Type: Active Pharmaceutical Ingredients, Finished Drug Products; By Drug Type: Innovators, Generics; By Therapeutic Area: Oncology, Neurology/CNS; By Stage Type: Clinical Phase, Commercial Manufactu...
May 20, 2026
U.S. Small Molecule Innovator API CDMO Market (By Stage Type: Clinical, Commercial, Preclinical; By Customer Type: Pharmaceutical Companies, Biotechnology Companies; By Therapeutic Area: Oncology, Cardiovascular Diseases, Neurology, Infectious Diseas...
January 06, 2026
Based on market forecasts, the bRo5 molecules market is witnessing rapid expansion due to increasing pharmaceutical R&D investments, growing adoption of AI-assisted drug discovery platforms, and rising oncology and CNS disorder prevalence. The ma...
April 24, 2026
Induced Proximity Molecules Market (By Molecule Type: PROTACs, Molecular Glues, LYTACs, AUTACs & ATTECs; By Target Protein Class: Kinases, Transcription Factors, Epigenetic Proteins, GPCRs & Membrane Proteins, Others; By Therapeutic Area: Onc...